Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders
European Patent
00923335.4
Filed on 2000-04-13
00923335.4
Filed on 2000-04-13
Utergolobin in The Treatment of IgA Meditated Automimmune Disorders
Canada
2370738
Filed on 2000-04-13
2370738
Filed on 2000-04-13
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE
Japan
1995-509336
Filed on 1994-09-15
1995-509336
Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE
European Patent
94928126.5
Filed on 1994-09-15
94928126.5
Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE
Canada
2171740
Filed on 1994-09-15
2171740
Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE
Australia
77284/94
Filed on 1994-09-15
77284/94
Filed on 1994-09-15
NOVEL RESTRICTION ENDONUCLEASE
Canada
593938
Filed on 1989-03-17
593938
Filed on 1989-03-17
NOVEL RESTRICTION ENDONUCLEASE
Australia
33559/89
Filed on 1989-03-17
33559/89
Filed on 1989-03-17
Nondenaturing Zwitterionic Detergents
France
82902934.7
Filed on 1982-08-19
82902934.7
Filed on 1982-08-19
Nondenaturing Zwitterionic Detergents
Austria
82902934.7
Filed on 1982-08-19
82902934.7
Filed on 1982-08-19